Metoclopramide Chelonia Healthcare

Metoclopramide, the active ingredient in Metoclopramide Chelonia Healthcare, is a dopamine antagonist (antiemetic) presented as an oral dosage form for oral use. It is employed to alleviate nausea and vomiting associated with postoperative recovery, chemotherapy, and gastrointestinal motility disorders such as gastroparesis, functional dyspepsia, and reflux esophagitis.

GNH USA supplies Metoclopramide Chelonia Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier, providing EU‑origin medication to hospitals, pharmacies and clinics worldwide.

Metoclopramide is used to manage conditions related to nausea, vomiting and delayed gastric emptying.

- Nausea and vomiting: reduces frequency and severity of nausea and vomiting in postoperative, chemotherapy‑induced and other causes. - Gastroparesis: enhances gastric motility and relieves symptoms of delayed gastric emptying. - Functional dyspepsia: alleviates upper abdominal discomfort, early satiety and bloating. - Reflux esophagitis: decreases reflux episodes by promoting faster gastric emptying.

Metoclopramide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness - Fatigue - Restlessness or agitation - Diarrhea - Dry mouth - Headache

Serious or Rare Side Effects: - Extrapyramidal symptoms, including tardive dyskinesia - Neuroleptic malignant syndrome - Severe depression or suicidal thoughts - Seizures - Anaphylactic or severe allergic reactions - Cardiac arrhythmias or QT prolongation

Before initiating therapy, consider the following precautions.

- Assess neurological history: patients with Parkinson’s disease or seizure disorders may be at higher risk. - Monitor for signs of depression or suicidal thoughts: report promptly. - Avoid prolonged use: limit to 12 days for nausea to reduce risk of tardive dyskinesia. - Use caution in renal impairment: dose adjustment may be required. - Pregnancy and lactation: consult a healthcare provider as safety data are limited. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture.

Metoclopramide can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent use with monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Co‑administration with other dopamine antagonists: additive extrapyramidal effects. - Combination with serotonergic agents (e.g., SSRIs, triptans): increased risk of serotonin syndrome. - Use with anticholinergic drugs: may enhance anticholinergic burden. - Interaction with CYP2D6 inhibitors (e.g., fluoxetine): increased metoclopramide plasma levels.

Moderate Interactions (Monitor Closely): - Concurrent use with CNS depressants (e.g., benzodiazepines, alcohol): may increase sedation. - Combination with other anti‑emetics such as ondansetron: possible additive anti‑emetic effect. - Use with drugs that prolong QT interval: monitor cardiac rhythm.